Ask your doctor about ImmunoFormulation (IF): A combination of nutraceuticals that can help COVID19 patients


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
The immune system is our defensive mechanism of the body that helps in fighting infection. Protecting your immune system with the administration of ImmunoFormulation (IF) can help you keep coronavirus at bay as per the evidence-based study.

COVID19 is caused by the acute respiratory distress syndrome coronavirus has being spread worldwide for more than a year. Although vast knowledge has been gathered about coronavirus, limited options are available for its treatment. We all understand with this coronavirus outbreak that “Prevention is better than cure”. In this context, agents that can act as prophylactics and adjuvants to the therapies are of high value. This includes a good amount of vitamin supplements and nutraceuticals that can help boost your immunity. 

Coronavirus affects and lowers the immune system

Weakened immunity can result in being more prone to infections like COVID19. When it comes to pathological findings, it is now clear that coronavirus involves the affection of the immune system with inflammatory effects. Preventing the coronavirus at an early stage can help you a lot. Taking vitamin supplements and nutraceuticals can help your body prevent the attack of coronavirus. Not to forget, the guidelines of social distancing, sanitizing, and wearing a mask are equally important. 

An observational study with  ImmunoFormulation (IF) treatment in SARS-Co-V-2 positive patients.

A study was carried out to describe the course of the disease SARS-Co-V2 on patients treated with ImmunoFormulation (IF). 

There were two groups of patients analyzed which are as follows:  

1)A group of patients who received ImmunoFormulation (IF) during the course of SARS-CoV-2

2) )A group of patients who did not receive ImmunoFormulation (IF) during the course of SARS-CoV-2

Screening criteria for an observational study 

All the patients attended the private clinic from March to May 2020. The data was collected in September 2020 for analysis. 40 patients were involved in the study who were tested positive in a diagnostic test for SARS-Co-V-2. 20 patients who received treatment with ImmunoFormulation (IF) were compared to another group of 20 patients who received standard care only. 

The screening criteria were as follows: 

Patients were 18 years of age or older  Patients have given written consent to participate in the study  The patients suffering from COVID19 symptoms from March to May 2020  Patients who were tested positive for the SARS-Co-V-2 diagnostic test  Patients with onset of COVID19 >5 days prior to the diagnosis of SARS-Co-V-2 

Results: A total of 40 patients participated in the study ( 20 in  ImmunoFormulation (IF) cohort study  / 20 on control cohort study). The patients were evaluated for efficacy of ImmunoFormulation (IF). The control cohort received standard care only and the  ImmunoFormulation (IF)cohort received standard care + ImmunoFormulation (IF). 

After comparison, It was observed in the  

ImmunoFormulation (IF) cohort observational study showed:

50% mild cases 

30 % moderate cases 

20% severe cases 

In the control cohort, an observational study showed: 

36.2% mild cases

26.3% moderate cases 

36.5% severe cases 

Throughout the observational study, 90% of patients recovered from the ImmunoFormulation (IF) cohort and 47.4% from the control cohort. The percentage of recovery in an observational study is better in the group treated with  ImmunoFormulation (IF). 

The conclusion from Observational study. 

In the treatment of COVID19, it is important to target the SARS-Co-V-2 to eliminate and improve the symptomatology by strengthening the natural defenses. Immune Formulation (IF) helped in abstaining fast recovery and better outcomes. A higher concentration of essential vitamins and minerals inhibited the replication of SARS-Co-V-2 avoiding the virus from entering the cell and multiply. This will help reduce the transmission of viruses from one person to another. 

Importance of  ImmunoFormulation (IF) and nutraceuticals

The study demonstrates that the consumption of vitamin supplements with a good amount of Vitamin D, Vitamin C, Vitamin B, Zinc, Selenium which has good antioxidant and antiinflammatory properties is good for the body to prevent the COVID19 and better recovery. These all vitamins will help contribute to reducing oxidative stress. This study promises the potential role of  ImmunoFormulation (IF) as adjuvant therapy in the COVID19 patients.  

Tags : #medicircle #myhealth #immunesystem #ImmunoFormulation #COVID19

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026
How Can Diabetes and High Blood Pressure Quietly Lead to Kidney Failure?September 30, 2026
Apollo Hospitals’ “My Hands Are Ready” Sets World Record Title with 61,221 CPR Pledges in 30 DaysSeptember 30, 2026
How Medical Device Trials and Validation Shape Safer Healthcare Innovation in IndiaSeptember 30, 2026
Medical Device Safety in India: What Patients Should Know About Recalls and AlertsSeptember 30, 2026